Cancer stem-like cells and thyroid cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Thyroid cancer incidence is rapidly increasing, with contributions from enhanced detection of well-differentiated types and papillary microcarcinomas.
• While many well-differentiated thyroid carcinomas have good prognoses, a subset, along with poorly differentiated and anaplastic types, exhibit fatal recurrent or metastatic disease.
• The cancer stem-like cell (CSC) model posits that a small subpopulation of cancer cells drives treatment resistance and metastatic potential.

Purpose of the Study:

• To review current research on thyroid cancer stem-like cells (CSCs).
• To discuss the roles of epithelial-to-mesenchymal transition (EMT) and mesenchymal-to-epithelial transition (MET) in CSC plasticity.
• To examine the involvement of microRNAs in CSC development and regulation within thyroid malignancies.

Main Methods:

• Literature review of studies focusing on thyroid CSCs.
• Analysis of research on EMT and MET processes in the context of CSCs.
• Review of investigations into microRNA functions related to CSCs in thyroid cancer.

Main Results:

• CSCs are implicated in the resistance to conventional therapies (chemotherapy, radiation) and the recurrence/metastasis of thyroid cancers.
• EMT and MET processes contribute to the plasticity and adaptability of CSCs, facilitating tumor growth and spread.
• MicroRNAs play a crucial role in the development and regulatory networks governing CSCs.

Conclusions:

• A deeper understanding of thyroid CSC biology, EMT/MET, and microRNA regulation is essential for advancing treatment strategies.
• Targeted therapies informed by CSC biology hold promise for improving outcomes in aggressive and fatal thyroid cancers.
• Further research into these mechanisms could lead to more rational and effective therapeutic designs for challenging thyroid cancer cases.